Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
+0.99%
1,093.81
+10.77
+0.99%
—1,083.041,082.631,099.011,080.59——
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
608.77
+6.39
+1.06%
—602.38602.38609.75599.75——
SIXE
Energy
SIXE
Energy
SIXE
+0.96%
1,254.81
+11.98
+0.96%
—1,242.831,229.311,258.881,220.51——
SIXI
Industrials
SIXI
Industrials
SIXI
+2.76%
1,761.11
+47.29
+2.76%
—1,713.821,715.471,763.111,715.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.40%
642.58
+2.59
+0.40%
—639.99636.98644.04631.81——
SIXR
Staples
SIXR
Staples
SIXR
+1.63%
851.13
+13.67
+1.63%
—837.46840.30852.55840.30——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.76%
217.98
+3.76
+1.76%
—214.22214.22218.25214.05——
SIXT
Technology
SIXT
Technology
SIXT
+0.23%
3,211.83
+7.45
+0.23%
—3,204.383,215.043,217.443,159.90——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.55%
948.98
+23.60
+2.55%
—925.38927.91949.76927.91——
SIXV
Health care
SIXV
Health care
SIXV
+2.20%
1,474.52
+31.81
+2.20%
—1,442.711,443.011,477.901,443.01——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.30%
2,392.12
+30.78
+1.30%
—2,361.342,391.002,399.182,354.52——
Mapato ya Q1 2026 • imetolewa • Imepitisha kiasi cha mapato kwa hisa +23.61% • Kiasi kilichotarajiwa cha mapato kimezidi +10.58%
Angalia matokeo
BIIB:NASDAQ
Biogen Inc
US$ 189.28
-2.62%
(-5.10) Siku 1
30 Apr, 16:00:01 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya BIIB...
Fungua
US$ 194.02
Juu
US$ 195.98
Chini
US$ 187.16
Mtaji wa soko
27.94B
Wastani wa kiasi cha mauzo
1.21M
Kiasi cha mauzo ya hisa
4.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
21.54
Juu kwa wiki 52
US$ 202.41
Chini kwa wiki 52
US$ 115.25
EPS
US$ 8.79
Beta
0.16
Hisa za wawekezaji
147.64M
Idadi ya wafanyakazi
elfu 8
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel fumarate, interferon beta-1a, peginterferon beta-1a, and natalizumab, all for the treatment of multiple sclerosis; nusinersen for the treatment of spinal muscular atrophy; omaveloxolone for the treatment of Friedreich's ataxia; tofersen for the treatment of ALS; and dimethyl fumarate for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs. The company is ranked 424th on the Fortune 500 and 845th on the Forbes Global 2000. Wikipedia
Kuhusu Biogen Inc
Afisa Mkuu Mtendaji (CEO)Chris Viehbacher
Wafanyakazielfu 7.5
Lilianzishwa1978
Makao makuuCambridge, Massachusetts, Marekani
Sekta-
Tovutibiogen.com
Ripoti ya mwisho
29 Apr 2026
Kipindi cha Kifedha
Robo1 2026
Mapato Yaliyosawazishwa kwa Kila Hisa au Kadirio
3.57/ (2.89 inakadiriwa)USD
+23.61%umepitiliza
Mapato au Kadirio
2.48B/ (2.24B inakadiriwa)USD
+10.58%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 1 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasariMaarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Jun 2025
Sep 2025
Des 2025
Mac 2026
Mapato
2.65B
2.53B
2.28B
2.48B
Gharama ya bidhaa zilizouzwa
946.20M
508.60M
443.40M
-
Gharama ya mapato
946.20M
508.60M
443.40M
-
Gharama za utafiti na maendeleo
-
431.80M
501.00M
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
581.30M
592.80M
685.20M
-
Gharama ya uendeshaji
783.70M
1.25B
1.39B
-
Jumla ya gharama za uendeshaji
1.73B
1.76B
1.83B
-
Mapato ya uendeshaji
915.60M
778.60M
447.70M
-
Mapato mengine yasiyo ya uendeshaji
-3.30M
15.80M
17.40M
-
EBT ikijumuisha vipengee visivyo vya kawaida
744.00M
557.30M
-56.00M
-
EBT bila kujumuisha vipengee visivyo vya kawaida
861.60M
748.30M
423.10M
-
Gharama ya kodi ya mapato
109.20M
90.80M
-7.10M
-
Kiwango cha kodi kinachotumika
14.68%
16.29%
12.68%
-
Gharama nyingine za uendeshaji
75.00M
87.20M
69.90M
-
Mapato halisi
634.80M
466.50M
-48.90M
-
Kiwango cha faida halisi
24.00%
18.40%
-2.15%
12.89%
Mapato kwa kila hisa
5.47
4.81
1.99
3.57
Mapato ya riba na uwekezaji
32.30M
31.60M
37.20M
-
Gharama ya riba
-72.60M
-67.40M
-67.50M
-
Jumla ya gharama halisi za riba
-40.30M
-35.80M
-30.30M
-
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
1.11B
980.80M
647.90M
-
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho